The impact of the introduction of bortezomib on dialysis independence in multiple myeloma patients with renal impairment: a nationwide Dutch population-based study.
Oortgiesen BE et al. Haematologica. 2018 Mar 15. pii: haematol.2017.184754. doi: 10.3324/haematol.2017.184754. [Epub ahead of print].
Multiple Myeloma Presenting as a Superscan on 68Ga-Pentixafor PET/CT.
Pan Q et al. Clin Nucl Med. 2018 Mar 13. doi: 10.1097/RLU.0000000000002067. [Epub ahead of print].
Defining cure in multiple myeloma: a comparative study of outcomes of young individuals with myeloma and curable hematologic malignancies.
Ravi P et al. Blood Cancer J. 2018 Feb 28;8(3):26. doi: 10.1038/s41408-018-0065-8.
Cutaneous seeding of neoplastic plasma cells to a site of bruising in a patient with relapsed myeloma.
Boyle S et al. Br J Haematol. 2018 Mar 12. doi: 10.1111/bjh.15172. [Epub ahead of print].
Is it feasible to conduct a randomised controlled trial of pretransplant exercise (prehabilitation) for patients with multiple myeloma awaiting autologous haematopoietic stem cell transplantation? Protocol for the PREeMPT study.
Keen C et al. BMJ Open. 2018 Mar 9;8(3):e021333. doi: 10.1136/bmjopen-2017-021333.
A systematic classification of death causes in multiple myeloma.
Mai EK et al. Blood Cancer J. 2018 Mar 8;8(3):30. doi: 10.1038/s41408-018-0068-5.
Proteasome inhibitors for the treatment of multiple myeloma.
Scalzulli E et al. Expert Opin Pharmacother. 2018 Mar;19(4):375-386. doi: 10.1080/14656566.2018.1441287. Epub 2018 Feb 26.
Light Chain Deposition Disease Associated With Multiple Myeloma Developing in Late Pregnancy.
Kim MJ et al. Iran J Kidney Dis. 2018 Mar;12(2):132-134.
Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis.
Maiese EM et al. Clin Ther. 2018 Mar;40(3):480-494.e23. doi: 10.1016/j.clinthera.2018.01.014. Epub 2018 Feb 28.
Phase II clinical trial of lenalidomide and dexamethasone therapy in Japanese elderly patients with newly diagnosed multiple myeloma to determine optimal plasma concentration of lenalidomide.
Kobayashi T et al. Ther Drug Monit. 2018 Feb 27. doi: 10.1097/FTD.0000000000000499. [Epub ahead of print].
Epidemiology of multiple myeloma in 17 Latin American countries: an update.
Curado MP et al. Cancer Med. 2018 Mar 24. doi: 10.1002/cam4.1347. [Epub ahead of print].
Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database.
Bhowmik D et al. J Med Econ. 2018 Mar 23:1-14. doi: 10.1080/13696998.2018.1457531. [Epub ahead of print].
Navigating the changing multiple myeloma treatment landscape: clinical practice patterns of MM patients treated in- and outside German DSMM study group trials.
Gengenbach L et al. Leuk Lymphoma. 2018 Mar 23:1-8. doi: 10.1080/10428194.2018.1448084. [Epub ahead of print].
Dramatically improved survival in multiple myeloma patients in the recent decade: results from a Swedish population-based study.
Thorsteinsdottir S et al. Haematologica. 2018 Mar 22. pii: haematol.2017.183475. doi: 10.3324/haematol.2017.183475. [Epub ahead of print].
Patient-reported outcomes in relapsed/refractory multiple myeloma: a systematic review.
Sparano F et al. Support Care Cancer. 2018 Mar 20. doi: 10.1007/s00520-018-4137-x. [Epub ahead of print].
Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?
Mian HS et al. Drugs Aging. 2018 Mar 19. doi: 10.1007/s40266-018-0539-1. [Epub ahead of print].
The Role of Allogeneic Transplantation for Multiple Myeloma in the Era of Novel Agents: a Study From the Japanese Society of Myeloma.
Kawamura K et al. Biol Blood Marrow Transplant. 2018 Mar 16. pii: S1083-8791(18)30125-3. doi: 10.1016/j.bbmt.2018.03.012. [Epub ahead of print].
Living With Multiple Myeloma: A Focus Group Study of Unmet Needs and Preferences for Survivorship Care.
Monterosso L et al. J Patient Exp. 2018 Mar;5(1):6-15. doi: 10.1177/2374373517715011. Epub 2017 Jul 26.
A rare case of multicentric castleman’s disease transforms into multiple myeloma and its successful treatment.
Yang D et al. Cancer Biol Ther. 2018 Mar 26:1-14. doi: 10.1080/15384047.2018.1456606. [Epub ahead of print].
Multiple Myeloma: Clinical Updates From the American Society of Hematology Annual Meeting, 2017.
Terpos E et al. Clin Lymphoma Myeloma Leuk. 2018 Mar 1. pii: S2152-2650(18)30157-5. doi: 10.1016/j.clml.2018.02.015. [Epub ahead of print].